<DOC>
	<DOCNO>NCT00783120</DOCNO>
	<brief_summary>Schizophrenia major psychotic disorder present enormous burden patient relatives . Despite treatment second generation antipsychotic , negative symptom cognitive impairment often persist determine unfavourable course include reduction life quality . Prefrontal repetitive transcranial magnetic stimulation ( rTMS ) , promise noninvasive biological technique , apply adjuvant ongoing antipsychotic treatment demonstrate safe associate improvement negative symptom majority small placebo-controlled trial . The primary objective trial investigate efficacy high-frequency rTMS ( add-on antipsychotic therapy ) treatment negative symptom schizophrenia compare sham stimulation ( placebo ) .</brief_summary>
	<brief_title>Repetitive Transcranial Magnetic Stimulation ( rTMS ) Treatment Negative Symptoms Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Male female inpatient outpatient , 18 60 year age Diagnostic criterion schizophrenia accord ICD10/DSM IV PANSS negative sum score &gt; 20 point , 1 item N1 N7 ( range 1 7 ) â‰¥ 4 ( least moderate ) Improvement PANSS negative sum score le 10 % last 2 week prior study entry , stable antipsychotic medication Informed Consent Clinically relevant psychiatric comorbidity , verbal IQ &lt; 85 History epileptic seizure , organic brain disease Instable medical comorbidity condition Previous treatment rTMS Factors compatible use TMS , e.g . cardiac pace maker metallic implant , pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>schizophrenia , negative symptom , TMS , magnetic stimulation</keyword>
</DOC>